Kalaris Therapeutics, Inc. (KLRS)
2.12
+0.12
(+6.00%)
USD |
NASDAQ |
Nov 03, 13:30
Kalaris Therapeutics Market Cap : 50.47M for Nov. 3, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 02, 2026 | 47.61M |
| October 30, 2026 | 48.32M |
| October 29, 2026 | 50.70M |
| October 28, 2026 | 47.85M |
| October 27, 2026 | 44.28M |
| October 26, 2026 | 42.85M |
| October 23, 2026 | 44.52M |
| October 22, 2026 | 47.37M |
| October 21, 2026 | 48.09M |
| October 20, 2026 | 49.28M |
| October 19, 2026 | 45.47M |
| October 16, 2026 | 47.61M |
| October 15, 2026 | 52.13M |
| October 14, 2026 | 50.70M |
| October 13, 2026 | 53.09M |
| October 12, 2026 | 53.80M |
| October 09, 2026 | 56.18M |
| October 08, 2026 | 59.51M |
| October 07, 2026 | 60.94M |
| October 06, 2026 | 63.32M |
| October 05, 2026 | 67.37M |
| October 02, 2026 | 64.27M |
| October 01, 2026 | 67.84M |
| September 30, 2026 | 68.80M |
| September 29, 2026 | 69.03M |
| Date | Value |
|---|---|
| September 28, 2026 | 67.73M |
| September 25, 2026 | 69.51M |
| September 24, 2026 | 73.08M |
| September 23, 2026 | 74.27M |
| September 22, 2026 | 77.13M |
| September 21, 2026 | 77.25M |
| September 18, 2026 | 76.18M |
| September 17, 2026 | 75.22M |
| September 16, 2026 | 75.70M |
| September 15, 2026 | 76.18M |
| September 14, 2026 | 78.56M |
| September 11, 2026 | 80.46M |
| September 10, 2026 | 78.56M |
| September 09, 2026 | 82.60M |
| September 08, 2026 | 86.41M |
| September 04, 2026 | 92.84M |
| September 03, 2026 | 93.79M |
| September 02, 2026 | 92.84M |
| September 01, 2026 | 93.32M |
| August 31, 2026 | 96.17M |
| August 28, 2026 | 95.93M |
| August 27, 2026 | 97.60M |
| August 26, 2026 | 97.12M |
| August 25, 2026 | 99.98M |
| August 24, 2026 | 97.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Replimune Group, Inc. | 1.920B |
| Arrowhead Pharmaceuticals, Inc. | 8.496B |
| Oncolytics Biotech, Inc. | 49.07M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.961B |
Market Cap Related Metrics
| Price to Book Value | 0.8750 |
| Price | 2.12 |
| Earnings Yield | -95.00% |